Evaluation of which reactive metabolite, if any, is responsible for a specific idiosyncratic reaction

被引:33
作者
Uetrecht, Jack [1 ]
机构
[1] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 2S2, Canada
关键词
animal models; nevirapine; tienilic acid; sulfamethoxazole; isoniazid; carbamazepine;
D O I
10.1080/03602530600959615
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Reactive metabolites are believed to be responsible for most idiosyncratic drug reactions. It is often assumed that if a reactive metabolite is found, it must be responsible for the idiosyncratic reactions associated with that drug. However, the evidence linking reactive metabolites and idiosyncratic reactions is circumstantial at best, and in many cases we have virtually no evidence. Furthermore, it is common for a drug to form several reactive metabolites, so it can be difficult to determine which, if any, is responsible for a given idiosyncratic reaction. Although the reactive metabolite hypothesis is logical, it has important implications for drug development, and we need to develop ways to test the hypothesis for specific drugs rigorously. Valid animal models are a powerful tool for testing whether a specific reactive metabolite is responsible for a specific adverse reaction and for studying further the mechanism by which it may induce such reactions; however, such models are rare.
引用
收藏
页码:745 / 753
页数:9
相关论文
共 31 条
[1]   Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine [J].
Bu, HZ ;
Kang, P ;
Deese, AJ ;
Zhao, P ;
Pool, WF .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (12) :1920-1924
[2]   Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development [J].
Evans, DC ;
Watt, AP ;
Nicoll-Griffith, DA ;
Baillie, TA .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (01) :3-16
[3]   CHARACTERIZATION OF THE MICROSOMAL EPOXIDE HYDROLASE GENE IN PATIENTS WITH ANTICONVULSANT ADVERSE DRUG-REACTIONS [J].
GAEDIGK, A ;
SPIELBERG, SP ;
GRANT, DM .
PHARMACOGENETICS, 1994, 4 (03) :142-153
[4]   GENETIC-ANALYSIS OF MICROSOMAL EPOXIDE HYDROLASE IN PATIENTS WITH CARBAMAZEPINE HYPERSENSITIVITY [J].
GREEN, VJ ;
PIRMOHAMED, M ;
KITTERINGHAM, NR ;
GAEDIGK, A ;
GRANT, DM ;
BOXER, M ;
BURCHELL, B ;
PARK, BK .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (09) :1353-1359
[5]   Electrospray ionization mass spectrometric analysis of intact cytochrome P450: Identification of tienilic acid adducts to P450 2C9 [J].
Koenigs, LL ;
Peter, RM ;
Hunter, AP ;
Haining, RL ;
Rettie, AE ;
Friedberg, T ;
Pritchard, MP ;
Shou, M ;
Rushmore, TH ;
Trager, WF .
BIOCHEMISTRY, 1999, 38 (08) :2312-2319
[6]   Can the pharmaceutical industry reduce attrition rates? [J].
Kola, I ;
Landis, J .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) :711-715
[7]   Studies on the sensitization of animals with simple chemical compounds [J].
Landsteiner, K ;
Jacobs, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1935, 61 (05) :643-U8
[8]   SPECIFICITY OF IN-VITRO COVALENT BINDING OF TIENILIC ACID METABOLITES TO HUMAN LIVER-MICROSOMES IN RELATIONSHIP TO THE TYPE OF HEPATOTOXICITY - COMPARISON WITH 2 DIRECTLY HEPATOTOXIC DRUGS [J].
LECOEUR, S ;
BONIERBALE, E ;
CHALLINE, D ;
GAUTIER, JC ;
VALADON, P ;
DANSETTE, PM ;
CATINOT, R ;
BALLET, F ;
MANSUY, D ;
BEAUNE, PH .
CHEMICAL RESEARCH IN TOXICOLOGY, 1994, 7 (03) :434-442
[9]  
Lecoeur S, 1996, MOL PHARMACOL, V50, P326
[10]   Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs [J].
Leeder, JS .
EPILEPSIA, 1998, 39 :S8-S16